Plaintiffs 3-for-4 in Philadelphia Risperdal trials
Plaintiffs 3-for-4 in Philadelphia Risperdal trials, confident punitive damages will be reintroduced If the results of the first trials are any indication, Janssen Pharmaceuticals might find itself with a hefty price tag connected to more than 1,600 Risperdal cases currently pending in Philadelphia, even without the prospect of paying punitive damages – though an appeal […]
$1.75 Million Jury Verdict
PHILADELPHIA, Nov. 11, 2015 /PRNewswire-USNewswire/ — A Philadelphia jury has awarded $1.75 million to a young man who claimed his taking the antipsychotic drug Risperdal caused him to grow female-like breasts. After only two-and-a-half hours of deliberation following a two week trial, the jury found that Risperdal, manufactured by Janssen Pharmaceuticals (a division of Johnson & Johnson), failed to warn health […]
BREAKING: $1.75M Verdict
A $1.75 million verdict in a Sheller firm antipsychotic drug Risperdal case was awarded today in Pennsylvania in the fourth case alleging Johnson & Johnson failed to warn of the risks of gynecomastia, the development of female-like breasts in boys and young men. The jury found the drug was a “substantial factor” in causing a […]
$2.5 Million Verdict
A Philadelphia jury awarded $2.5 million to a twenty year old man whose family claimed he developed female-like breasts (gynecomastia) from taking the antipsychotic drug Risperdal for five years from ages eight to thirteen. Stephen A. Sheller, attorney for the family: “We are encouraged to see this day come, after ten years of our pursuing […]
SuperLawyers 2013: seven Sheller, P.C. attorneys honored
2013-05-17 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2013/05/Sheller_PASLRS13_FINAL.pdf”] The law firm of Sheller, P.C. announces the selection of six attorneys as Pennsylvania SuperLawyers® and one as Pennsylvania Rising Star for 2013. Stephen A. Sheller is once again honored for the tenth straight year, and for the fourth year as a Top 100 Philadelphia and Top 100 Pennsylvania SuperLawyers®. Also for […]
$1.4 Billion Whistleblower Settlement
2009-01-15 Sheller, P.C.’s whistleblower/qui tam clients help U.S. government recover $1.4 billion record settlement and criminal fine in Eli Lilly & Company Zyprexa marketing case. [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/ShellerPC_ZyprexaNewsRelease_200901152.pdf”]
Sheller Investigation Restores Ringwood Site to Superfund List
Ringwood Mines/Landfill site became the first site to be added to the National Priorities List after being removed from the list On April 16, 2006. The decision to restore Ringwood’s Superfund status came after an investigation that was initiated by Stephen Sheller of Sheller, P.C. This was the first instance of a site that had […]
